Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SGPL1 | O95470 | 4/20 | 0.44 |
| ▸ | FDPS | P14324 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | LAP3 | P28838 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14848265 | 1.00 | SGPL1 (0.44) | SGPL1FDPSLMNADNM1TSHR | |
| SCHEMBL13637149 | 1.00 | SGPL1 (0.44) | SGPL1FDPSLMNADNM1TSHR | |
| SCHEMBL16358397 | 0.98 | SGPL1 (0.42) | SGPL1FDPSLMNADNM1TSHR | |
| SCHEMBL13827706 | 0.96 | SGPL1 (0.41) | SGPL1FDPSLMNADNM1TSHR | |
| SCHEMBL15368891 | 0.96 | SGPL1 (0.41) | SGPL1FDPSLMNADNM1TSHR | |
| SCHEMBL16180731 | 0.95 | SGPL1 (0.40) | SGPL1FDPSLMNADNM1LAP3 | |
| SCHEMBL27472493 | 0.91 | SGPL1 (0.41) | SGPL1FDPSLMNADNM1TSHR | |
| SCHEMBL13784736 | 0.90 | SGPL1 (0.42) | SGPL1FDPSLMNATSHRLAP3 | |
| SCHEMBL23038570 | 0.88 | SGPL1 (0.39) | SGPL1FDPSLMNADNM1LAP3 | |
| SCHEMBL17554254 | 0.87 | LMNA (0.48) | SGPL1FDPSLMNALAP3CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113645977-A | Compounds, compositions and methods for treatment of disease | F-星治疗公司 | 2021-11-12 | — | — | CN | disclosed |